These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8608647)

  • 21. Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis.
    Ogushi F; Tani K; Maniwa K; Ichikawa W; Tada H; Kawano T; Sone S
    J Med Invest; 1997 Aug; 44(1-2):53-8. PubMed ID: 9395718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis.
    Katoh S; Matsubara Y; Taniguchi H; Fukushima K; Mukae H; Kadota J; Matsukura S; Kohno S
    Clin Exp Immunol; 2001 Dec; 126(3):545-50. PubMed ID: 11737075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells.
    Kawakami K; Kadota J; Iida K; Fujii T; Shirai R; Matsubara Y; Kohno S
    Clin Exp Immunol; 1997 Feb; 107(2):410-6. PubMed ID: 9030883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels of soluble adhesion molecules in serum of patients with diffuse panbronchiolitis.
    Mukae H; Kadota J; Ashitani J; Taniguchi H; Mashimoto H; Kohno S; Matsukura S
    Chest; 1997 Dec; 112(6):1615-21. PubMed ID: 9404762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
    Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
    Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers.
    Mikuniya T; Nagai S; Tsutsumi T; Morita K; Mio T; Satake N; Izumi T
    Respiration; 1999; 66(5):419-26. PubMed ID: 10516538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of peripheral airway findings using an ultrathin bronchofiberscope and bronchoalveolar lavage fluid with diffuse panbronchiolitis.
    Kikawada M; Ichinose Y; Minemura K; Takasaki M; Toyama K
    Respiration; 1998; 65(6):433-40. PubMed ID: 9817957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone.
    Park JW; Taube C; Swasey C; Kodama T; Joetham A; Balhorn A; Takeda K; Miyahara N; Allen CB; Dakhama A; Kim SH; Dinarello CA; Gelfand EW
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):830-6. PubMed ID: 14754758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-antibiotic effect of antibiotics.
    Kadota Ji JI
    Clin Microbiol Infect; 1996 Jun; 1 Suppl 2():S20-S22. PubMed ID: 11866799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.
    Tillie-Leblond I; Pugin J; Marquette CH; Lamblin C; Saulnier F; Brichet A; Wallaert B; Tonnel AB; Gosset P
    Am J Respir Crit Care Med; 1999 Feb; 159(2):487-94. PubMed ID: 9927362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interleukin-1beta and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis].
    Wu YF; Tan C; Zhang JY; Meng S; Guo YH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):683-6. PubMed ID: 15460419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis.
    Park SJ; Lee YC; Rhee YK; Lee HB
    Biochem Biophys Res Commun; 2004 Nov; 324(1):114-7. PubMed ID: 15464990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
    Matsumoto K
    Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of efficacy of erythromycin on diffuse panbronchiolitis--effect of erythromycin on cytokine mRNA expression in human whole blood model].
    Akiyoshi H; Honda J; Nakahara S; Tokisawa S; Tokunaga N; Ichikawa Y; Oizumi K
    Kansenshogaku Zasshi; 1994 Feb; 68(2):209-16. PubMed ID: 8151147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis.
    Barlo NP; van Moorsel CH; Korthagen NM; Heron M; Rijkers GT; Ruven HJ; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2011 Dec; 166(3):346-51. PubMed ID: 22059992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
    Oishi K; Sonoda F; Kobayashi S; Iwagaki A; Nagatake T; Matsushima K; Matsumoto K
    Infect Immun; 1994 Oct; 62(10):4145-52. PubMed ID: 7927669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor associated carbohydrate antigens in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
    Mukae H; Sakito O; Oda H; Senju R; Fukushima K; Hiratani K; Kadota J; Komori K; Kohno S; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2075-81. PubMed ID: 1289627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in cellular and inflammatory cytokine profiles in the bronchoalveolar lavage fluid in bagassosis and silicosis.
    Zhai R; Ge X; Li H; Tang Z; Liao R; Kleinjans J
    Am J Ind Med; 2004 Oct; 46(4):338-44. PubMed ID: 15376226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.